
Anglotaz 4.5gm Injection
Marketer
Brook Parker
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Anglotaz 4.5gm Injection
Combiflox 4.5g Injection is a dual-antibiotic formulation indicated for diverse bacterial infections. Its mechanism involves microbial eradication. Administration should always be performed by a qualified medical practitioner; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, tailored to your specific condition's severity. Adherence to the prescribed regimen is crucial. Commonly reported adverse effects include gastrointestinal upset (nausea, vomiting, diarrhea) and dermatological reactions (rash). Injection site reactions such as pain, inflammation, or erythema may also occur. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, hepatic, or renal impairments; dosage adjustments or alternative therapies may be necessary. Under medical guidance, this injection is generally considered safe for pregnant and breastfeeding individuals.
Uses of Anglotaz 4.5gm Injection
Infections caused by bacteria
Major Benefits of Anglotaz 4.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Anglotaz 4.5gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Anglotaz 4.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Anglotaz 4.5gm Injection works:
Anglotaz 4.5gm Injection blends Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum counters bacterial resistance mechanisms, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Anglotaz 4.5gm Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Anglotaz 4.5gm is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Anglotaz, 4.5 grams, presents minimal risk during lactation. Research in human subjects indicates negligible transfer of the medication into breast milk, posing no discernible threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Anglotaz 4.5gm Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Anglotaz 4.5gm Injection cautiously. Dosage modification of Anglotaz 4.5gm Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Anglotaz 4.5gm Injection in patients with liver impairment appears to pose minimal risk. Preliminary findings indicate that dosage modification may be unnecessary for this patient population. Physician consultation is recommended.
What if you forget to take Anglotaz 4.5gm Injection :
Omit a dose of Anglotaz 4.5gm Injection? Seek medical advice immediately.
Facts to Know About Anglotaz 4.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
